Neoleukin Therapeutics (NLTX) Stock Chart & Stock Price History $22.64 +0.57 (+2.56%) (As of 12/20/2024 ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrends Neoleukin Therapeutics Stock Price Performance 5 Day Performance-3.70%1 Month Performance+47.68%3 Month Performance-44.44%6 Month Performance-27.13%Year-To-Date Performance+16.82%1 Year Performance+53.08% Receive NLTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neoleukin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin NLTX Stock Chart for Saturday, December, 21, 2024 NLTX Chart by TradingView Neoleukin Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/20/2024$21.79$22.08+1.31%$23.20$21.34299,837 shs$207.46 million12/19/2024$23.72$21.79-8.14%$24.02$21.68303,613 shs$204.78 million12/18/2024$25.13$23.72-5.61%$25.35$22.92296,478 shs$222.92 million12/17/2024$23.51$25.13+6.89%$25.18$22.97280,445 shs$236.17 million12/16/2024$23.51$23.51$24.37$21.85253,097 shs$220.95 million12/13/2024$23.20$22.34-3.73%$24.06$21.68304,068 shs$209.90 million Get the Latest News and Ratings for NLTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neoleukin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/12/2024$23.70$23.20-2.11%$24.20$22.59178,353 shs$218.03 million12/11/2024$23.70$23.70$25.11$22.99442,688 shs$222.73 million12/10/2024$23.31$23.70+1.67%$25.11$22.99437,251 shs$222.73 million12/09/2024$23.72$23.31-1.73%$25.53$23.00195,203 shs$219.07 million12/06/2024$22.02$21.99-0.14%$22.59$21.44246,149 shs$206.66 million12/05/2024$22.34$22.02-1.43%$22.25$20.82494,449 shs$206.94 million12/04/2024$24.57$22.34-9.08%$24.39$22.03519,047 shs$209.95 million12/03/2024$25.43$24.57-3.38%$25.93$24.49555,084 shs$230.91 million12/02/2024$25.43$25.43$26.75$24.78318,069 shs$238.99 million11/29/2024$25.80$25.43-1.43%$26.75$24.78317,555 shs$238.99 million11/28/2024$26.87$25.80-3.98%$27.68$24.60530,879 shs$242.47 million11/27/2024$22.32$26.87+20.41%$27.61$24.231.33 million shs$252.52 million11/26/2024$20.30$22.32+9.93%$22.57$20.501.30 million shs$209.72 million11/25/2024$20.30$20.30$20.93$15.481.06 million shs$190.78 million11/22/2024$15.33$20.30+32.42%$20.93$15.481.06 million shs$190.78 million11/21/2024$17.23$15.33-11.03%$17.45$15.28802,176 shs$144.07 million11/20/2024$19.82$17.23-13.07%$20.99$17.011.23 million shs$161.93 million Related Companies CorMedix Stock Price Chart AnaptysBio Stock Price Chart Xeris Biopharma Stock Price Chart ABIVAX Société Anonyme Stock Price Chart MeiraGTx Stock Price Chart Cartesian Therapeutics Stock Price Chart Alpha Teknova Stock Price Chart Monte Rosa Therapeutics Stock Price Chart ChromaDex Stock Price Chart Organogenesis Stock Price Chart Receive NLTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neoleukin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NLTX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neoleukin Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neoleukin Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
